본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
A case of obstructive jaundice caused by tuberculous lymphadenitis: A literature review Su Jung Baik, Kwon Yoo, Tae Hun Kim, Il Hwan Moon, Min-Sun Cho pp.208-213

Pure red-cell aplasia and autoimmune hemolytic anemia in a patient with acute hepatitis A Hyo Jeong Chang, Dong Hyun Sinn, Sung Gyun Cho, Tae Hoon Oh, Tae Joo Jeon, Won Chang Shin, Won Choong Choi pp.204-207

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh pp.177-184

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang pp.168-176

Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population : a cross-sectional study Hai Jin Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Chang Hong Lee pp.154-161

Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013 : experience at a single center in Korea Sung Jun Chung, Tae Yeob Kim, Sun Min Kim, Min Roh, Mi Yeon Yu, Jung Hoon Lee, ChangKyo Oh, Eun Young Lee, Seung Lee, Yong Cheol Jeon, Kyo-Sang Yoo, Joo Hyun Sohn pp.162-167

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh pp.192-203

Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee pp.185-191

참고문헌 (36건) : 자료제공( 네이버학술정보 )

참고문헌 목록에 대한 테이블로 번호, 참고문헌, 국회도서관 소장유무로 구성되어 있습니다.
번호 참고문헌 국회도서관 소장유무
1 REFERENCES 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917. 미소장
2 Recurrent hepatocellular carcinoma after liver transplantation – an emerging clinical challenge 네이버 미소장
3 Liver transplantation in association with hepatocellular carcinoma: An update of the International Tumor Registry 네이버 미소장
4 Low Recurrence Rate of Hepatocellular Carcinoma after Liver Transplantation: Better Patient Selection or Lower Immunosuppression? 네이버 미소장
5 Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. 네이버 미소장
6 Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence 네이버 미소장
7 Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors: Reassessment of Risk Factors for Tumor Recurrence 네이버 미소장
8 Cyclosporine induces cancer progression by a cell-autonomous mechanism. 네이버 미소장
9 Chen ZS, He F, Zeng FJ, Jiang JP, Du DF, Liu B. Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2007;13:5273-5276. 미소장
10 Sirolimus‐based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma 네이버 미소장
11 U.S. Food and Drug Administration (FDA). Rapamune highlights of prescribing information. FDA web site, . Accessed 2013. 12. 미소장
12 Hepatitis B Immunoglobulins Inhibit Dendritic Cells and T Cells and Protect Against Acute Rejection After Liver Transplantation 네이버 미소장
13 Yi NJ, Lee KW, Kong SY, Park KU, Lee KB, Hong G, et al. Outcome of various treatments for posttransplant hepatitis B virus recurrence. World J Surg 2013;37:812-819 미소장
14 Optimizing use of basiliximab in liver transplantation 네이버 미소장
15 THE ROLE OF 18F-FDG-PET IMAGING FOR THE SELECTION OF LIVER TRANSPLANTATION CANDIDATES FROM AMONG HEPATOCELLULAR CARCINOMA PATIENTS. 네이버 미소장
16 The Role of Liver Transplantation in Hepatobiliary Malignancy. A Retrospective Analysis of 95 Patients with Particular Regard to Tumor Stage and Recurrence 네이버 미소장
17 Current controversies surrounding liver transplantation for hepatocellular carcinoma 네이버 미소장
18 Management of hepatocellular carcinoma 네이버 미소장
19 Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma 네이버 미소장
20 Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis 네이버 미소장
21 Majno P, Giostra E, Mentha G; Geneva liver cancer study. Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma? J Hepatol 2005;43:577-584. 미소장
22 Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, et al. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol 2006;12:7319-7325. 미소장
23 BASILIXIMAB INDUCTION IN ADULT LIVER TRANSPLANT RECIPIENTS WITH 93% REJECTION FREE PATIENT AND GRAFT SURVIVAL AT 24 MONTHS. 네이버 미소장
24 Basiliximab in a Triple-Drug Regimen With Tacrolimus and Steroids in Liver Transplantation 네이버 미소장
25 Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience1 네이버 미소장
26 Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer. 네이버 미소장
27 Basiliximab 네이버 미소장
28 Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 네이버 미소장
29 Circulating AFP mRNA as a Possible Indicator of Hematogenous Spread of HCC Cells: A Possible Association with HBV Infection. 네이버 미소장
30 Liver Transplantation for Advanced Hepatocellular Carcinoma 소장
31 Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. 네이버 미소장
32 The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. 네이버 미소장
33 Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation 네이버 미소장
34 Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis 네이버 미소장
35 Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. 네이버 미소장
36 Simplified staging for hepatocellular carcinoma. 네이버 미소장